Active, Not Recruiting
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
- Locations
-
- Exelixis Clinical Site #6 Duarte, California, United States
- Exelixis Clinical Site #49 La Jolla, California, United States
- Exelixis Clinical Site #7 Los Angeles, California, United States
- Exelixis Clinical Site #84 Los Angeles, California, United States